QIAGEN powered by
Publication Roundup: QIAGEN CLC Genomics Workbench

QIAGEN Digital Insights Monday, April 13, 2020

Recently, there have been many noteworthy papers citing QIAGEN CLC Genomics Workbench, a comprehensive, easy-to-use toolbox that ensures continuity in…

Publication Roundup: Biomedical Genomics Workbench

QIAGEN Digital Insights Wednesday, November 7, 2018

Publication Roundup: Biomedical Genomics Workbench Check out these recent articles citing Biomedical Genomics Workbench, a comprehensive, highly accurate NGS data…

Low frequency variant detection with increased accuracy

QIAGEN Digital Insights Friday, October 7, 2016

Using new QIAseq DNA Targeted Panels with Biomedical Genomics Workbench increases the accuracy of detecting low frequency variants. We are…

Enhance your data analysis experience with our new releases

QIAGEN Digital Insights Friday, September 16, 2016

We’re happy to announce that new releases of our products are now available. The releases offer a number of new features and improvements. You can…

Advances in hereditary and rare diseases

QIAGEN Digital Insights Friday, June 10, 2016

We recently returned from beautiful Barcelona, where we attended the 49th annual meeting for the European Society of Human Genetics…

Improve variant analysis and case solve rate

QIAGEN Digital Insights Wednesday, March 30, 2016

Looking back at ACMG 2016 where speakers looked ahead to improved variant analysis Inspiring talks at ACMG We recently attended the…

Raising the profile of rare disease

QIAGEN Digital Insights Monday, February 29, 2016

Living with a rare disease is often lonely and isolating for patients and caregivers alike. Through our work with researchers…

Whole human genome analysis

QIAGEN Digital Insights Tuesday, November 3, 2015

Your $1,000 genome will only cost $22 to analyze We’re committed to enabling our customers to analyze vast amounts of…

QIAGEN launches new bioinformatics solution for hereditary diseases

QIAGEN Digital Insights Wednesday, October 7, 2015

We are pleased to announce the launch of our new end-to-end solution for hereditary diseases; an offering including Biomedical Genomics Workbench, Biomedical…